Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE

Size: px
Start display at page:

Download "Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE"

Transcription

1 UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS UMHHC-HCS: First Approved Date: 3/2010 Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE Current Approved Date: 8/31/12 Approval Signatures: Signatures on File TITLE: Subcutaneous Immune Globulin Therapy (SCIg) POLICY: A. Subcutaneous immunoglobulin (SCIg) is administered upon a physician s orders. B. The nurse administering SCIg shall be knowledgeable of the indications for use, appropriate dosage, administration, monitoring parameters, side effects, toxicities, incompatibilities, stability, storage requirements, and potential complications. C. First dose of SCIg may be given in the home with strict adherence to first dosing requirements and only when the pt meets first home dose eligibility criteria. Patients who may be excluded: 1. Allergy profile consistent with a known anaphylactic or severe systemic response (hypersensitivity) to immune globulin or blood products 2. Pregnancy 3. Selective IgA deficiency 4. Clinician judgment. D. First home doses of SCIg will be restricted to administration on weekdays during business hours with a physician available. E. First home doses of SCIg will be restricted to use of HomeMed nursing or subcontracted nursing agencies who have been educated and proven competent to administer SCIg. DEFINITIONS: Mechanism of Action: SCIg provides passive immunity by increasing the individual s antibody titer. Uses: Primary immunodeficiency, defects in humoral immunity and autoimmune disorders PROCEDURES: A. Referral Processing 1. All referrals will be processed according to existing practice. Referrals received by the pharmacy for a first home dose of SCIg will be screened by the branch team accordingly against established eligibility criteria. Failure to meet eligibility criteria will result in declination of the referral and communication to the prescriber. 2. Eligibility criteria as listed are designed to serve as a guide and may not be all inclusive. Therefore, collaboration with the prescribing physician is necessary to evaluate any potential risks inherent to SCIg. B. Obtain and review the physician s order for the following: 1. Oral pre-medication (e.g., acetaminophen, diphenhydramine). The patient is educated to obtain and self-administer the necessary oral pre-medications 30 minutes prior to the initiation of the SCIg infusion to minimize the potential for adverse effects.

2 Page 2 of 6 C. SCIg 2. Anaphylaxis Kit: For first dosing in the home (Note: a HomeMed Anaphylaxis Kit must be available in the home at all times during SCIg administration) a. Contents of HomeMed adult Anaphylaxis Kit (for patients 30 kg) i) Diphenhydramine 50 mg/ml (1 syringe) ii) iii) Sodium Chloride 0.9% 500mL bag (1 bag) Epinephrine 0.3 mg (Epipen ) (2 syringes) b. Contents of HomeMed pediatric Anaphylaxis Kit (for patients > 15 kg and < 30 kg) i) Diphenhydramine 50 mg/ml syringe (1 syringe) ii) iii) Sodium Chloride 0.9% 500mL bag (1 bag) Epinephrine 0.15mg (Epipen Jr ) (2 syringes) 3. Anaphylaxis Kit: For patients who have received immune globulin previously without reaction epinephrine must be available in the home at all times during SCIg administration. a. Contents of HomeMed adult Anaphylaxis Kit (for patients 30 kg) i) Epinephrine 0.3 mg (Epipen ) (2 syringes) b. Contents of HomeMed pediatric Anaphylaxis Kit (for patients > 15 kg and < 30 kg) i) Epinephrine 0.15mg (Epipen Jr ) (2 syringes) 4. Patients less than 15 kg in weight require individualized weight based dosing of epinephrine. 5. Patients/caregiver will be instructed on the administration and indications for use of epinephrine. 1. Dose and concentration a. Convert monthly dose in grams to weekly dose in milliliters i) Monthly IVIG dose/gram divided by treatment interval = weekly IVIG dose per gram ii) Weekly IVIG dose per gram divided by 0.16 = weekly IVIg dose per ml b. Calculate initial weekly dose i) Weekly IVIG dose/ml X 1.37 = Initial Weekly dose ml c. Determine the number of weekly infusion sites i) Initial weekly dose per ml divided by 15 ml per infusion site = total number of infusion sites (round to the nearest whole number) d. Calculate initial weekly dose per injection site i) Initial weekly dose/ml divided by number of weekly infusion sites = initial weekly dose/ml per infusion site e. Note: to convert milliliters to grams, multiply milliliters by Rate of administration should not exceed 15 ml per site at rate of 20 ml per hour.

3 Page 3 of 6 3. Access to order the correct flow rate tubing. 4. Parameters for vital signs (see Administration of SCIg, H.1.) 5. Laboratory orders (assess for IgA antibody, Ig levels, kidney/liver studies if indicated). D. Note: If specific parameters for SCIg infusion administration have not been ordered, the nurse or pharmacist will clarify the prescription with the prescriber. The nurse will administer SCIg according to manufacturer recommendations and policy guidelines. E. Assessment & Education 1. Identify the patient by using two identifiers 2. Review orders, lab results and assess appropriateness of therapy. 3. Assess allergy history including allergic responses to human immune globulin or blood products 4. Assess past medical history for risk factors or contraindications 5. Assess for previous post SCIg infusion side effects or adverse reactions 6. Assess patient for recent or ongoing infections. If the patient has an oral temperature of F or greater, notify physician. 7. Assess for disease response to previous SCIg/IVIg treatments. 8. Educate the patient (e.g., acquisition and use of pre-medications, adverse reactions, product storage, and administration). F. Preparation of SCIg for administration. 1. Locate the anaphylaxis kit in the home. Check expiration date and re-order as needed. 2. Inspect drug label, solution, equipment, and supplies. Verify the tubing flow rate matches the prescription. 3. Wash hands. 4. Prepare clean work surface. 5. Gather supplies. 6. Assemble equipment. 7. Obtain baseline vital signs. 8. Aseptically withdraw SCIg from vial using appropriate syringe: a. Remove cap from vial and vigorously wipe vial stopper with an alcohol wipe for 15 seconds. Allow the vial stopper to dry. b. Lay SCIg vial on flat surface, insert needle into the center of the vial stopper. c. Invert the SCIg vial, fill syringe and remove d. Repeat as necessary to achieve the prescribed dose. 9. Purge air from syringe 10. Attach SCIg syringe to infusion pump tubing.

4 Page 4 of Prime pump tubing by gently pushing on the syringe plunger or by priming on infusion pump.. G. Administration of SCIg 1. Ensure patient has self- administered or administer oral premeds as ordered 2. Select an appropriate infusion site(s), depending on the amount required. The abdomen, thighs, upper arms hip areas are recommended. 3. Cleanse the site(s) with an alcohol wipe beginning in the center of the site, working outward in a circular motion. If more that one site is required, ensure that each site is 2 inches apart. Allow site(s) to dry. 4. Using 2 fingers grasp the skin around the selected infusion site and insert needle into the subcutaneous tissue. 5. Following needle insertion, attach empty 10 ml syringe to end of tubing and gently pull back on the syringe plunger to check for proper placement. If blood returns, remove and discard the needle and administration tubing. Replace needle(s) using new needle, tubing and infusion site(s). 6. Secure the needle(s) by applying a sterile gauze or transparent dressing over the site and tape in place. 7. Load SCIg filled syringe into the clear plastic tube of the infusion pump. a. Loosen the end of the tubing b. Turn pump on by rotating the recessed switch to the ON position and prime tubing. c. Once primed, swab the needle free connector with an alcohol wipe and connect to the indwelling catheter H. Monitor for adverse reactions. 1. Vital signs should be taken every 15 minutes x 2; then hourly until the infusion is completed. Vital signs may be taken less frequently in future infusions if the patient has tolerated well and without incidence of reaction. 2. Adverse effects are usually apparent within minutes after the start of infusion. a. Exception: Anaphylaxis, which can be immediate. b. Adverse reactions are caused by an interaction of antibodies in the IVIG with antigens present in the patient at the time of infusion. Symptoms and interventions are listed in Exhibit A. 3. After the infusion is complete, rotate the switch to the OFF position and rewind the pump fully. 4. Remove the used syringe by gently pulling and lifting out. 5. Remove the needle(s) from the insertion site(s). 6. Apply an appropriate dressing to the site(s) as needed. 7. Discard syringe, tubing and needles into sharps container. 8. Chart response to therapy.

5 Page 5 of 6 EXHIBITS: 1. Symptoms Related to IVIG Administration and Interventions REFERENCES: 1. First Dose Medication Administration APPROVAL AND REVISIONS: 1. March 2010 New procedure 2. August 2012: added web site to order correct flow rate tubing; added to instruct patient/caregiver on anaphylaxis administration.

6 Page 6 of 6 Symptoms Exhibit 1 Symptoms Related to SCIg Administration and Interventions Interventions Local injection site reactions (Expected & Assess for tape/transparent dressing allergy should decrease within 24 to 48 hours can last 15 minutes or up to 4 days) Assess size should be consistent with volume infused & amount of subcutaneous tissue Redness/rash Assess length of catheter may be too short with fluid Blanching leaking into intradermal layer Itching Assess site location may be too close to muscle Discomfort Decrease rate of infusion or decrease volume per site Swelling Avoid tracking medication thru the intradermal tissue by not allowing drops of SCIg on the needle tip prior to needle insertion Assess appropriateness of rotating sites Consider use of topical anesthetic cream Extreme pain or discomfort, blistering or Observe/change technique spreading redness Assess needle length may be too long and irritant abdominal wall Change catheter to soft tip needle Adjust infusion regimen (number of sites, volume per site, and rate of infusion) Apply ice or topical anesthetic cream prior to insertion Leaking at the catheter site Ensure catheter is affixed securely and fully inserted Assess placement may be in location that is subject to movement Length of catheter may be too short Amount per site may be too great; adjust volume Assess rate of infusion adjust rate Long infusion time Bring SCIg to room temperature Adjust infusion regimen (volume per site, rate of infusion, number of sites) Check for correct tubing size and length to match infusion rates, check pump function Observe patient technique Headache (usually observed several days following administration and may last 1 to 2 Acetaminophen 10 to 15 milligrams per kilogram po as needed days) Prescribed medication Nausea/Vomiting Stop infusion until subsides. Antiemetics may be useful. Adjust infusion regimen (number of sites, volume per site, and rate of infusion) Hypotension/Hypertension -Monitor blood pressure Stop the infusion until blood pressure returns to normal, and then resume infusion May require decrease in rate of infusion. Anaphylaxis -Monitor blood pressure -Monitor pulse -Monitor respiration If anaphylaxis occurs (hives, wheezing, chest tightness, or respiratory distress), stop the infusion immediately, follow anaphylactic guidelines and call M.D. or 911.

SCIG INFUSIONS A PRACTICAL GUIDE FOR PATIENTS

SCIG INFUSIONS A PRACTICAL GUIDE FOR PATIENTS PRIMARY IMMUNODEFICIENCIES SCIG INFUSIONS: A PRACTICAL GUIDE FOR PATIENTS SCIG INFUSIONS A PRACTICAL GUIDE FOR PATIENTS 1 PRIMARY IMMUNODEFICIENCIES ABBREVIATIONS IG IVIG PID SCIG Immunoglobulin Intravenous

More information

STEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID

STEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID STEP-BY-STEP GUIDE TO SELF-INFUSION Subcutaneous Administration of GAMMAGARD LIQUID This handy guide will help you manage your subcutaneous administration of GAMMAGARD LIQUID. If you have questions on

More information

EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3

EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3 EVOGAM Information for patients 11179 Evogam NZ Patient Brochure Update FA3 Information for patients and caregivers about EVOGAM This booklet is designed to help you follow the training you will have been

More information

Ig Therapy: One Size Does Not Fit All

Ig Therapy: One Size Does Not Fit All Ig Therapy: One Size Does Not Fit All Carla Duff, CPNP, MSN, IgCN Advanced Registered Nurse Practitioner University of South Florida Division of Allergy, Immunology, and Rheumatology 1 Objectives Understand

More information

EVOGAM. Information for patients Evogam 2014 NZ Patient Brochure Update v11

EVOGAM. Information for patients Evogam 2014 NZ Patient Brochure Update v11 EVOGAM Information for patients 11881 Evogam 2014 NZ Patient Brochure Update v11 Information for patients and caregivers about EVOGAM This booklet is designed to help you follow the training you will have

More information

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration.

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration. Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration. Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain

More information

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

If viewing a printed copy of this policy, please note it could be expired. Got to  to view current policies. If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Code: D: PC-5555 Entity: Fairview Pharmacy Services

More information

ATI Skills Modules Checklist for Central Venous Access Devices

ATI Skills Modules Checklist for Central Venous Access Devices For faculty use only Educator s name Score Date ATI Skills Modules Checklist for Central Venous Access Devices Student s name Date Verify order Patient record Assess for procedure need Identify, gather,

More information

Human Normal Immunoglobulin 20% (20 g per 100 ml), solution for subcutaneous administration.

Human Normal Immunoglobulin 20% (20 g per 100 ml), solution for subcutaneous administration. Human Normal Immunoglobulin 20% (20 g per 100 ml), solution for subcutaneous administration. Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does

More information

How to Use ENBREL : Vial Adapter Method

How to Use ENBREL : Vial Adapter Method How to Use ENBREL : Vial Adapter Method SETTING UP FOR AN INJECTION Select a clean, well-lit, flat working surface, such as a table. Take the ENBREL dose tray out of the refrigerator and place it on your

More information

Patient Information Publications Warren Grant Magnuson Clinical Center National Institutes of Health

Patient Information Publications Warren Grant Magnuson Clinical Center National Institutes of Health Warren Grant Magnuson Clinical Center National Institutes of Health What is a subcutaneous injection? A subcutaneous injection is given in the fatty layer of tissue just under the skin. A subcutaneous

More information

Education for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath

Education for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath HOME IV THERAPY PICC Portacath Who To contact Cardio-Respiratory Integrated Specialist Services (CRISS) Office hours 0800 1630 hours Ph: 364 0167 Weekends and after hours, phone Christchurch Hospital operator

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION ALPROLIX [pronounced all prō liks] Coagulation Factor IX (Recombinant), Fc Fusion Protein This leaflet is part III of a three-part "Product Monograph" published when ALPROLIX

More information

INFORMATION FOR THE CONSUMER

INFORMATION FOR THE CONSUMER INFORMATION FOR THE CONSUMER This insert provides a summary of the information about CETROTIDE (cetrorelix for injection). If you have any questions or concerns, or want more information about CETROTIDE,

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION ALPROLIX [pronounced all prō liks] Coagulation Factor IX (Recombinant), Fc Fusion Protein This leaflet is part III of a three-part "Product Monograph" published when ALPROLIX

More information

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

If viewing a printed copy of this policy, please note it could be expired. Got to  to view current policies. If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Code: D: PC-5575 Entity: Fairview Pharmacy Services

More information

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS:

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS: ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Read the Instructions for Use before you start using ALPROLIX and each time you get a refill. There may be new information.

More information

MICAFUNGIN MIXING

MICAFUNGIN MIXING 1 1-800-862-2731 MICAFUNGIN MIXING Drug Name: MICAFUNGIN Volume and Rate: over 1 hour Schedule: KEY POINTS: FLUSHING: Saline Micafungin Saline Heparin 1. Always wash your hands with an antibacterial soap

More information

SELF-INJECTION GUIDE

SELF-INJECTION GUIDE SELF-INJECTION GUIDE (asfotase alfa) 40 mg/ml solution for injection 18 mg/0.45 ml 28 mg/0.7 ml 40 mg/1 ml 100 mg/ml solution for injection 80 mg/0.8 ml asfotase alfa Introduction Contents This Self-Injection

More information

IMPORTANT: PLEASE READ. Don t

IMPORTANT: PLEASE READ. Don t PATIENT/CAREGIVER INSTRUCTIONS FOR USE - ORENCIA (ABATACEPT) PREFILLED SYRINGE WITH BD ULTRASAFE PASSIVE TM NEEDLE GUARD WITH FLANGE EXTENDERS Getting started with ORENCIA therapy Did you receive self-injection

More information

Pfizer, BeneFIX R2 Recombinant Factor IX

Pfizer, BeneFIX R2 Recombinant Factor IX Pfizer, BeneFIX R2 Recombinant Factor IX BeneFIX, Recombinant Factor IX, is indicated for the prevention and control of bleeding episodes in people with hemophilia B (Christmas Disease). BeneFIX is also

More information

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin HOME IV THERAPY Tobramycin Tobramycin Check the order on the drug chart This can change when the results from your blood test come through. Your doctor will change the order, if required. A copy of the

More information

Instructions for Use Enbrel (en-brel) (etanercept) for injection, for subcutaneous use Multiple-dose Vial

Instructions for Use Enbrel (en-brel) (etanercept) for injection, for subcutaneous use Multiple-dose Vial Instructions for Use Enbrel (en-brel) (etanercept) for injection, for subcutaneous use Multiple-dose Vial How do I prepare and give an injection with Enbrel multiple-dose vial? A multiple-dose vial contains

More information

GAMUNEX. If you have any concerns about receiving this medicine, ask your doctor or pharmacist.

GAMUNEX. If you have any concerns about receiving this medicine, ask your doctor or pharmacist. New Zealand Consumer Medicine Information GAMUNEX Normal Immunoglobulin (Human), 10% for Intravenous or Subcutaneous Administration What is in this leaflet This leaflet answers some common questions about

More information

Methotrexate Injections

Methotrexate Injections UW MEDICINE PATIENT EDUCATION Methotrexate Injections Steps to follow Your provider has prescribed that you receive methotrexate by injection. This handout explains the drug, its side effects, drug interactions,

More information

Department Policy. Code: D:PC Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual

Department Policy. Code: D:PC Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Midline (Extended Dwell Peripheral) Catheter Care and Management

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide For needle and needle-free systems This guide provides detailed instructions on the reconstitution, dilution, and storage of VELETRI. It is intended to be used after your

More information

Gammanorm, 165 mg/ml, solution for injection Human normal immunoglobulin

Gammanorm, 165 mg/ml, solution for injection Human normal immunoglobulin PACKAGE LEAFLET: INFORMATION FOR THE USER Gammanorm, 165 mg/ml, solution for injection Human normal immunoglobulin Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.

More information

Instructional Guide RECONSTITUTION OF IDELVION USING THE MIX2VIAL TRANSFER SET

Instructional Guide RECONSTITUTION OF IDELVION USING THE MIX2VIAL TRANSFER SET Instructional Guide RECONSTITUTION OF IDELVION USING THE MIX2VIAL TRANSFER SET The only FDA-approved treatment for hemophilia B with up to 14-day dosing* * In appropriate people 12 years and older. Talk

More information

Home Health Foundation, Inc. To create more permanent IV access for patients undergoing long term IV therapy.

Home Health Foundation, Inc. To create more permanent IV access for patients undergoing long term IV therapy. PROCEDURE ORIGINAL DATE: 06/99 Revised Date: 09/02 Home Health Foundation, Inc. SUBJECT: PURPOSE: MIDLINE CATHETER INSERTION To create more permanent IV access for patients undergoing long term IV therapy.

More information

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: Nursing DATE: REVIEWED: PAGES: RESPONSIBILITY: RN, LPN 07/81 9/10 1 of 5 PURPOSE: 1. To maintain aseptic technique in preparing and administering

More information

Package leaflet: Information for the user. Cuvitru 200 mg/ml solution for subcutaneous injection Human normal immunoglobulin

Package leaflet: Information for the user. Cuvitru 200 mg/ml solution for subcutaneous injection Human normal immunoglobulin Package leaflet: Information for the user Cuvitru 200 mg/ml solution for subcutaneous injection Human normal immunoglobulin This medicine is subject to additional monitoring. This will allow quick identification

More information

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION NiaStase RT (eptacog alfa, activated) Activated Recombinant Human Blood Coagulation Factor VII Room Temperature Stable This leaflet is Part III of

More information

STANDARDIZED PROCEDURE REPROGRAMMING AND REFILLING INTRATHECAL BACLOFEN PUMPS and ACCESSING THE CATHETER ACCESS PORT (Adult,Peds)

STANDARDIZED PROCEDURE REPROGRAMMING AND REFILLING INTRATHECAL BACLOFEN PUMPS and ACCESSING THE CATHETER ACCESS PORT (Adult,Peds) I. Definition The purpose of this procedure is to allow the Advanced Health Practitioner (AHP) to reprogram and refill intrathecal Baclofen pumps, as well as access the catheter access port for those AHPs

More information

Preparation and Administration

Preparation and Administration Preparation and Administration A guide for healthcare professionals XOLAIR IS INDICATED FOR: Adults and adolescents (aged 12 years) with moderate-to-severe persistent asthma who have a positive skin test

More information

INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF ENBREL POWDER

INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF ENBREL POWDER INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF ENBREL POWDER Introduction The following instructions explain how to prepare and inject Enbrel powder for injection. Please read the instructions carefully

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide This guide provides detailed instruction on the reconstitution, dilution, and storage of Veletri (epoprostenol) for Injection. It is intended to be used after your healthcare

More information

BAYER: KOGENATE FS WITH BIOSET (Recombinant FVIII)

BAYER: KOGENATE FS WITH BIOSET (Recombinant FVIII) BAYER: KOGENATE FS WITH BIOSET (Recombinant FVIII) KOGENATE FS, Recombinant Antihemophilic Factor, is indicated for the prevention and control of bleeding episodes in people with hemophilia A (classical

More information

Normal Immunoglobulin (Human), 10% for Intravenous or Subcutaneous Administration

Normal Immunoglobulin (Human), 10% for Intravenous or Subcutaneous Administration Normal Immunoglobulin (Human), 10% for Intravenous or Subcutaneous Administration Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain

More information

Instructions for Use Enbrel (en-brel) (etanercept) injection, for subcutaneous use Single-dose Prefilled Syringe

Instructions for Use Enbrel (en-brel) (etanercept) injection, for subcutaneous use Single-dose Prefilled Syringe Instructions for Use Enbrel (en-brel) (etanercept) injection, for subcutaneous use Single-dose Prefilled Syringe How do I prepare and give an injection with Enbrel Single-dose Prefilled Syringe? There

More information

SARASOTA MEMORIAL HOSPITAL. NURSING PROCEDURE INTRAOSSEOUS NEEDLE: INSERTION, CARE, AND REMOVAL (inv08) 12/18 12/18 1 of 7 RESPONSIBILITY:

SARASOTA MEMORIAL HOSPITAL. NURSING PROCEDURE INTRAOSSEOUS NEEDLE: INSERTION, CARE, AND REMOVAL (inv08) 12/18 12/18 1 of 7 RESPONSIBILITY: SARASOTA MEMORIAL HOSPITAL TITLE: ISSUED FOR: NURSING PROCEDURE INTRAOSSEOUS NEEDLE: INSERTION, CARE, AND REMOVAL (inv08) Nursing DATE: REVIEWED: PAGES: 12/18 12/18 1 of 7 RESPONSIBILITY: PS1094 Insertion-

More information

Instructions for Use HEMLIBRA (hem-lee-bruh) (emicizumab-kxwh) injection, for subcutaneous use

Instructions for Use HEMLIBRA (hem-lee-bruh) (emicizumab-kxwh) injection, for subcutaneous use Instructions for Use HEMLIBRA (hem-lee-bruh) (emicizumab-kxwh) injection, for subcutaneous use Be sure that you read, understand, and follow the Instructions for Use before injecting HEMLIBRA. Your healthcare

More information

Title: EZ-IO. Effective Date: January SOG Number: EMS Rescinds:

Title: EZ-IO. Effective Date: January SOG Number: EMS Rescinds: S O G Title: EZ-IO Effective Date: January 2010 SOG Number: EMS - 25 Rescinds: Scope: Providers Authorized are AIC s in the following certifications EMT-I and EMT-P who have been trained and cleared by

More information

Baxter, ADVATE Antihemophilic Factor (Recombinant)

Baxter, ADVATE Antihemophilic Factor (Recombinant) Baxter, ADVATE Antihemophilic Factor (Recombinant) ADVATE, Recombinant Antihemophilic Factor, is indicated for the prevention and control of bleeding episodes in people with hemophilia A (classical hemophilia).

More information

A patient guide to administration of subcutaneous immunoglobulin replacement therapy - using manual push technique

A patient guide to administration of subcutaneous immunoglobulin replacement therapy - using manual push technique A patient guide to administration of subcutaneous immunoglobulin replacement therapy - using manual push technique This piece of patient information is a step by step guide to administering your immunoglobulin

More information

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) PATIENT / USER INFORMATION LEAFLET Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) Read all of this leaflet carefully before you start taking this medicine. Keep this

More information

Instructions for Use Enbrel (en-brel) (etanercept) Single-use Prefilled SureClick Autoinjector

Instructions for Use Enbrel (en-brel) (etanercept) Single-use Prefilled SureClick Autoinjector Instructions for Use Enbrel (en-brel) (etanercept) Single-use Prefilled SureClick Autoinjector How do I prepare and give an injection with Enbrel Single-use Prefilled SureClick Autoinjector? This section

More information

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use .3 mg per vial _ A healthcare provider should show you how to inject MYALEPT before you use it for the first time. A healthcare provider should also watch you inject your MYALEPT dose the first time you

More information

HOW TO USE... 5mg. Pocket Guide

HOW TO USE... 5mg. Pocket Guide HOW TO USE... Pocket Guide 4 ZOMACTON [somatropin (rdna origin)] for Injection Supplies ZOMACTON 5 mg (powder) Preparation syringe Syringe and injection needle Diluent (liquid) Diluent (liquid) contains

More information

What Biostate is used for

What Biostate is used for Biostate Human coagulation factor VIII (FVIII) and human von Willebrand factor (VWF) complex, powder for injection. Consumer Medicine Information Biostate 250 IU FVIII/500 IU VWF: AUST R 73032 Biostate

More information

The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel.

The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel. Instructions for Use Welcome! The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel. Your healthcare provider has prescribed Enbrel SureClick autoinjector

More information

INSULIN INJECTION KNOW-HOW

INSULIN INJECTION KNOW-HOW 0-1- INSULIN INJECTION KNOW-HOW Learning how to Congratulations for making the move to insulin therapy. It won t be long before you start enjoying better blood sugar control, more energy, and a host of

More information

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale Standard operating procedures for preparation and administration of intramuscular injections Preparation Overview No Action Rationale 1 Collect and check all equipment 2 Check that the packaging of all

More information

How to give an injection of hydrocortisone

How to give an injection of hydrocortisone Act-O-Vial Instructions (Solu-Cortef) Act-O-Vial (Solu-Cortef) is a medicine used to treat many diseases such adrenal insufficiency in emergency situations. This medicine is given if you cannot take steroid

More information

ASSESSMENT AND CARE Monitor for the following and remove catheter if there is: redness, pain, swelling, firm tissue, exudates, bleeding or leakage.

ASSESSMENT AND CARE Monitor for the following and remove catheter if there is: redness, pain, swelling, firm tissue, exudates, bleeding or leakage. POLICY An Indwelling subcutaneous catheter may be inserted when an infant requires regular subcutaneous injections (At least one subcutaneous injection per day). SUPPORTIVE DATA In the NICU medications

More information

ARROW EZ-IO Intraosseous Vascular Access System Procedure Template

ARROW EZ-IO Intraosseous Vascular Access System Procedure Template ARROW EZ-IO Intraosseous Vascular Access System Procedure Template PURPOSE To provide procedural guidance for establishment of intraosseous vascular access using the ARROW EZ-IO Intraosseous Vascular Access

More information

MABEES. MFR & Basic EMT Epinephrine Study

MABEES. MFR & Basic EMT Epinephrine Study MABEES MFR & Basic EMT Epinephrine Study Acknowledgements This program is a State of Michigan approved special study designed by members of the Oakland County Medical Control Authority American CME developed

More information

Step-by-step instructions for intravenous (iv) infusions for patients with:

Step-by-step instructions for intravenous (iv) infusions for patients with: Step-by-step instructions for intravenous (iv) infusions for patients with: Rheumatoid Arthritis (RA) Systemic Juvenile Idiopathic Arthritis (sjia) Polyarticular Juvenile Idiopathic Arthritis (pjia) Please

More information

Infusion Skills Competency Checklist To be used at annual skills fair or at any other time for IV Competency

Infusion Skills Competency Checklist To be used at annual skills fair or at any other time for IV Competency Employee Profile Infusion Skills Checklist Last Name First Name Middle Initial Employee Number Employee Discipline Check one: RN LPN Per state specific LPN Practice Acts Direct Supervisor s Name: Date

More information

Patient Information. EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use

Patient Information. EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use Patient Information EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use Read the Patient Information that comes with EGRIFTA before you start to take it and each time you get a refill.

More information

Instructions for Use. For use with. 10 mg vial

Instructions for Use. For use with. 10 mg vial Instructions for Use For use with 10 mg vial Table of Contents Parts of the ZOMA-Jet 10... 1 Supplies you will need to mix a ZOMACTON 10 mg Vial... 2 Mix a ZOMACTON 10 mg vial... 3 Reset the ZOMA-Jet 10...

More information

KINGSTON GENERAL HOSPITAL NURSING POLICY AND PROCEDURE

KINGSTON GENERAL HOSPITAL NURSING POLICY AND PROCEDURE KINGSTON GENERAL HOSPITAL NURSING POLICY AND PROCEDURE SUBJECT Sample (Adult): Advanced Competency (AC) for Nurses (Registered Nurses and Registered Practical Nurses) PAGE 1 of 5 ORIGINAL ISSUE 1985 January

More information

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: INTERMITTENT FLUID AND MEDICATION THERAPY Nursing DATE: REVIEWED: PAGES: RESPONSIBILITY: RN, LPN I, LPN II Per Job Description 03/81 8/09

More information

How Berinert works. Before you are given. Berinert. When you must not have it

How Berinert works. Before you are given. Berinert. When you must not have it Human C1 esterase inhibitor, powder for injection. Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information.

More information

Central venous access devices for children with lysosomal storage disorders

Central venous access devices for children with lysosomal storage disorders Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Central venous access devices for children with lysosomal storage disorders This information explains about central

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Teduglutide for injection

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Teduglutide for injection READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr REVESTIVE * Teduglutide for injection Read this carefully before you start taking REVESTIVE and each time you get

More information

Glatopa is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

Glatopa is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS). PATIENT INFORMATION Glatopa (gluh-toh-puh) (Glatiramer Acetate Injection) for Subcutaneous Use Read this Patient Information before you start using Glatopa and each time you get a refill. There may be

More information

Self-Injection Instructions for Injectable Gold

Self-Injection Instructions for Injectable Gold Self-Injection Instructions for Injectable Gold A Guide for Patients Mary Pack Arthritis Centre 895 West 10th Avenue Vancouver BC V5Z 1L7 Tel: 604-875-4021 What to Have Ready Ampoule of medication Sterile

More information

1 Ig. Prescribed for PI

1 Ig. Prescribed for PI 1 Ig # Prescribed for PI Hizentra is a prescription medicine used to treat primary immune deficiency (PI) in patients 2 years and older. *Ig=Immunoglobulin Please see full on pages 12 13 and full prescribing

More information

Drew University Health Service 36 Madison Avenue Madison, New Jersey Tel: Fax:

Drew University Health Service 36 Madison Avenue Madison, New Jersey Tel: Fax: Dear Student, Enclosed you will find our policies, procedures and student consent form for your allergy immunotherapy. We ask that you read them carefully, sign the consent form, and take the physician

More information

IV Fluids. Nursing B23. Objectives. Serum Osmolality

IV Fluids. Nursing B23. Objectives. Serum Osmolality IV Fluids Nursing B23 Objectives Discuss the purpose of IV Discuss nursing interventions in IV therapy Identify complications of IV therapy Differentiate between peripheral line, central line, and PICC

More information

Successful IV Starts Revised February 2014

Successful IV Starts Revised February 2014 Successful IV Starts Revised February 2014 Why Intravenous Therapy? Used for access to the body s circulation Indications: Administer fluids, blood, medications, and nutrition Obtain laboratory specimens

More information

PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES. Insulin

PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES. Insulin PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES Insulin This medicine has been proven to be safe and effective, but it can cause serious injury if a mistake happens while taking it. This means

More information

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Syringe (75 mg/ml)

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Syringe (75 mg/ml) Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Syringe (75 mg/ml) Important Information The device is a single-dose pre-filled syringe.

More information

The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel.

The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel. Instructions for Use Welcome! The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel. Your healthcare provider has prescribed Enbrel SureClick autoinjector

More information

EL DORADO COUNTY EMS AGENCY FIELD PROCEDURES

EL DORADO COUNTY EMS AGENCY FIELD PROCEDURES EL DORADO COUNTY EMS AGENCY FIELD PROCEDURES Effective: July 1, 2017 Reviewed: November 9, 2016 Revised: November 9, 2016 EMS Agency Medical Director INTRAOSSEOUS INFUSION PURPOSE: To establish immediate

More information

Standard Operating Procedure for cannulation

Standard Operating Procedure for cannulation Standard Operating Procedure for cannulation Effective date: 26.07.2017 Review due date: 31.03.2019 Original Author Name: Richard Metcalfe Position: PhD Student Date: 05.12.2012 Reviewer Name: Pippa Heath

More information

Vial. A healthcare provider should show you how to inject MYALEPT before you use it for

Vial. A healthcare provider should show you how to inject MYALEPT before you use it for MYALEPT (metreleptin) for injection Instructions for Use MYALEPT (MAI-uh-lept) (metreleptin) for injection Vial A healthcare provider should show you how to inject MYALEPT before you use it for 8 Do not

More information

REVESTIVE teduglutide Consumer Medicine Information

REVESTIVE teduglutide Consumer Medicine Information teduglutide Consumer Medicine Information What is in this leaflet Please read this leaflet before you start using. This leaflet answers some common questions about. It does not contain all the available

More information

BUTTONHOLE CANNULATION

BUTTONHOLE CANNULATION BUTTONHOLE CANNULATION What is a Buttonhole? Technique in which an AV fistula is cannulated in the exact same spot, at the same angle and at the same depth of penetration every time. Benefits Reduction

More information

OCMCA Education Task Force. Practical Skill Guide

OCMCA Education Task Force. Practical Skill Guide OCMCA Education Task Force Practical Skill Guide MFR & Basic MFR/EMT Epinephrine Study (MABEES) Practical Component In-service training: MFR & Basic MFR/EMT Epinephrine Study (MABEES) Purpose: Every licensed

More information

Administer Parenteral Drugs

Administer Parenteral Drugs Administer Parenteral Drugs Intradermal, subcutaneous, intramuscular, or intravenous. To prepare and administer parenteral medications the nurse must have knowledge of the special equipment, use manual

More information

Prothrombinex -HT Human prothrombin complex, freeze-dried.

Prothrombinex -HT Human prothrombin complex, freeze-dried. Consumer Medicine Information Prothrombinex -HT Human prothrombin complex, freeze-dried. AUST R 64012 What is in this leaflet This leaflet answers some common questions about Prothrombinex -HT. It does

More information

Infusion of intravenous gamma globulin (immunoglobulins)

Infusion of intravenous gamma globulin (immunoglobulins) Infusion of intravenous gamma globulin (immunoglobulins) OBJECTIVES Intravenous gamma globulin therapy is indicated for replacement therapy in patients with primary and secondary antibody deficiency syndromes.

More information

To provide nursing staff with guidelines for the safe and appropriate administration of insulin.

To provide nursing staff with guidelines for the safe and appropriate administration of insulin. SUBJECT: ADMINISTRATION OF INSULIN This cancels NP 513 dated 3/1/07 1. PURPOSE: COALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION - Medications POLICY NUMBER: 513 Effective Date: June

More information

CATHETERIZATION TRAINER ON A STAND

CATHETERIZATION TRAINER ON A STAND CATHETERIZATION TRAINER ON A STAND Parts identification: Clamp Prostate velcro strap (male genitalia only) Genitalia stand male female Urethra channel Bladder tubing and luer locks Female genitalia Male

More information

Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe. Plunger rod Used plunger rod

Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe. Plunger rod Used plunger rod Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe Guide to parts Before use After use Plunger rod Used plunger rod Finger grip Label

More information

Hizentra Infusion Guide

Hizentra Infusion Guide Hizentra Infusion Guide Step-by-step instructions for self-administering Hizentra Use this guide only as a supplement to the Hizentra full prescribing information and to personal instruction from your

More information

GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION

GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION Includes Example dose calculation wheel Preparation and administration information for healthcare professionals Please see enclosed full Prescribing Information,

More information

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Background: In September 2015, Illinois passed a new law, PA99-0480, expanding access to the opioid

More information

Life back in their hands 1 3

Life back in their hands 1 3 Life back in their hands 1 3 11153 Evogam NZ Updated HCP Brochure Update FA5 New Zealand s own SCIg 1 New Zealand plasma. New Zealand self-sufficiency. 1,4,5 EVOGAM is manufactured from plasma donated

More information

Parts identification:

Parts identification: TRANSPARENT CATHETERIZATION SIMULATOR Parts identification: Clamp Urethra channel Prostate velcro strap (male genitalia only) Transparent Simulator Bladder tubing and luer locks Female genitalia Male genitalia

More information

Instruction For Use for All Silicon Foley Catheter

Instruction For Use for All Silicon Foley Catheter General Description: All Silicone Foley Catheter for single use is a thin, is a flexible tube passed through the urethra and into the bladder to drain urine. It is the most common type of indwelling urinary

More information

Patient/Carer instructions for the administration of Subcutaneous Cytarabine

Patient/Carer instructions for the administration of Subcutaneous Cytarabine Patient/Carer instructions for the administration of Subcutaneous Cytarabine This document covers the following information: What cytarabine is What subcutaneous means What happens if you decide to inject

More information

Sharps Container (not included) 1 Gather and check supplies. Gather supplies

Sharps Container (not included) 1 Gather and check supplies. Gather supplies Instructions for Use BENLYSTA (ben-list-ah) (belimumab) injection, for subcutaneous use Prefilled Syringe Read this Instructions for Use before you start to use BENLYSTA and each time you refill your prescription.

More information

Human coagulation factor VIII (FVIII) and human von Willebrand factor (VWF) complex, powder for injection. are essential for normal blood clotting.

Human coagulation factor VIII (FVIII) and human von Willebrand factor (VWF) complex, powder for injection. are essential for normal blood clotting. Biostate Human coagulation factor VIII (FVIII) and human von Willebrand factor (VWF) complex, powder for injection. Consumer Medicine Information What is in this leaflet This leaflet answers some common

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user ReFacto AF 250 IU powder and solvent for solution for injection ReFacto AF 500 IU powder and solvent for solution for injection ReFacto AF 1000 IU powder and solvent

More information

4/8/2013. Chapter 9: Administration by the Parenteral Route. Any route other than the GI tract

4/8/2013. Chapter 9: Administration by the Parenteral Route. Any route other than the GI tract Chapter 9: Administration by the Parenteral Route Drug is absorbed into circulation thru numerous blood vessels located in the mucosa of the area Buccal- medication placed between cheek and gum Sublingual-

More information

STEP-BY-STEP INJECTION INSTRUCTIONS

STEP-BY-STEP INJECTION INSTRUCTIONS STEP-BY-STEP INJECTION INSTRUCTIONS Acthar is a prescription medicine for the reduction of proteinuria in people with nephrotic syndrome of the idiopathic type (unknown origin) without uremia (accumulation

More information